Compare CubeSmart (CUBE) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CubeSmart vs 10X Genomics Inc — how do they compare? CubeSmart trades at $40.86 (market cap $9.20B), while 10X Genomics Inc trades at $59.24 (market cap $7.61B). The key difference: CubeSmart is the larger of the two by market cap, and CubeSmart pays a 5.19% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| CUBE | TXG | |
|---|---|---|
Market Cap | $9.20B | $7.61B |
Sector | Real Estate | Health |
52-Week High | $42.50 | $58.57 |
52-Week Low | $35.36 | $11.34 |
Enterprise Value | $12.72B | $7.14B |
Dividend Yield | 5.19% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About CubeSmart
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. CubeSmart derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
Read more on CUBE →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
